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I.

INTRODUCTION
Intellectual property (IP) has an important role in a country’s academic, social, political, and above all,

economic development. IP is rising above tangible properties; and creators, inventors, authors along with
new technology and access to the internet, are changing the world every day. The activities which seemed
impossible a decade ago, are happing frequently with minimum cost in a short amount of time. Hence, the
IP right guarantees protection for the new creation, invention, or the work of authorship; and provides an
incentive for enhancement of such creations in the future too.
Although, IP is a very developed field in most of the Developed Countries (DCs),1 especially in the
United States. It is a very new, unrecognized field of law in Afghanistan. For instance, according to the
World Intellectual Property Organization (WIPO), the United States legal platform in IP is large in that it
includes forty-two IP-centered laws and sixty-five IP-related laws.2 In contrast, Afghanistan only has three
IP-centered laws and eighteen IP-related laws.3 However, Afghanistan has put certain attention on IP laws
since 2000, by adopting the three main IP laws, such as the law on Protection of Patent Rights, Trademark
Registration Law, and Copyright Law.
Although IP protection and advances, undoubtedly, offer several economic and developmental
advantages to a country, it also has its disadvantages, especially in the least Developed Countries (LDCs).4
IP works like a double-edged sword, in a way that the rich countries get richer, and the poor countries get
poorer. Because the DCs have the resources, technologies, and capital to invest and work on new inventions
every day, which results in gaining more profit from protected products or inventions. While LDCs do not

According to the United Nations’ (UN) country classification, Developed Countries are the countries which have
developed economy and high incomes. While the UN also has three other categories of countries, such as countries
in Transaction, Developing Countries, and Least developed Countries, determined by the United Nations Economic
and Social Council based on the recommendation of by the Committee for Development Policy. United Nations
New York, World Economic Situation and Prospects (2020), available at
https://www.un.org/development/desa/dpad/wp-content/uploads/sites/45/WESP2020_Annex.pdf.
2
WIPO IP Portal, United States of America (last visited Mar. 3, 2021), available at
http://www.wipo.int/wipolex/en/profile.jsp?code=US.
3
WIPO IP Portal, United States of America (last visited Mar. 3, 2021), available at
http://www.wipo.int/wipolex/en/profile.jsp?code=AF.
4
United Nations New York, supra note 1.
1
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have such opportunities, so it makes it harder for them to work on new inventions or gain IP-generated
profit.
Indeed, IP can contribute to a country’s economical, societal, or even political landscape and rule of
law,5 but, to get there, every country needs some level of stability or support in the initial stages of building
its IP protection system or adopting a legal framework for IP. However, the International institutions, such
as WIPO or the World Trade Organization (WTO), have taken some steps to facilitate the Developing or
LDCs in terms of adopting IP platforms, or access to Medicines via Trade Related Aspects of Intellectual
Property Rights (TRIPS) or Doha Declaration, but those steps been challengeable themselves.
This paper will briefly and comparatively review the IP platform in the United States (as a DC) and
Afghanistan (as an LDC) and will discuss the IP rights’ advantages and disadvantages, at the same time.
To do that, the paper will focus on (I) Copyright and Access to Information, (II) Patent and Access to
Pharmaceutical Products, and (III) Trademark and Challenges of LDCs.

II.

COPYRIGHT AND ACCESS TO INFORMATION
The difference in legal systems between the United States and Afghanistan has its significance in

defining what is Copyright, or what could be protected. The United States as a Common Law Country
follows stare decisis (judgments issued by a higher court of the same jurisdiction) as a primary source of
law along with the Constitution or Statutes. It gives the courts some legislative power in defining a term or
deciding on a dispute.6 Afghanistan follows a Civil Law system, meaning the laws are written or codified
into collections by a bi-assembly Parliament rather than being determined by judges.7 This part will provide

5

Shahid Alikhan, The Role of Copyright in the Cultural and Economic Development of Developing Countries, J.
Intell. Prop. Rights, at 489, 490 (Nov. 2002), available at
http://nopr.niscair.res.in/bitstream/123456789/4938/1/JIPR%207(6)%20489-505.pdf.
6
Toni M. Fine, LexisNexis, Intro to American Legal System (last visited Apr. 10, 2021), available at
https://www.lexisnexis.com/en-us/lawschool/pre-law/intro-to-american-legal-system.page.
7
Eli Sugarman et al., An Introduction to the Laws of Afghanistan: Afghanistan Legal Education Project (3rd ed.
2011), available at https://www-cdn.law.stanford.edu/wp-content/uploads/2016/03/ALEP-Law-of-Afghanistan-3dEd_English.pdf.
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an overview of Copyright Laws in the United States and Afghanistan first. Then, it will cover the Access
to Information or Technology challenges and Copyright Limitations.

A. Overview
The Constitution provides the ground for IP protection; the language of the Constitution in the
United States reads, "the Congress shall have the power to promote the progress of science by securing for
limited times to author … the exclusive right to their … writing."8 The law refers to copyright as promoting
the progress of science.9 On the other hand, the Constitution of Afghanistan provides the ground toward
protecting copyright matter as it states:
“The state shall devise effective programs for fostering knowledge, culture, literature and
arts. The state shall guarantee the copyrights of authors, inventors and discoverers, and, shall
encourage and protect scientific research in all fields, publicizing their results for effective use in
accordance with the provisions of the law.”10
This definition implies a combination of how the American and European countries define
copyright. For instance, the United Kingdom focuses on Copyright as an economic11 and property right12
that protects the expression of original ideas, which can be literary,13 artistic,14 musical, sound recordings,
films, broadcasts, typographical arrangements and published editions.15 While the European approach
focuses more on the literal and artistic sides of the work, the American approach is more on encouraging
and promoting scientific research.
Furthermore, the first Article of the copyright law in Afghanistan focuses on the purpose of the
copyright law stating that this law is adopted “to protect the economical and moral rights of the works of

8

U.S. Const. art. I, § 8, cl. 8.
Id.
10
Afg. Const. art. 47.
11
Bently et al., Intellectual Property Law, 304 (5th ed. 2018).
12
Copyright Designs and Patent Act 1988, c. 48 (UK), https://www.legislation.gov.uk/ukpga/1988/48/contents.
13
Id. at § 3.
14
Id. at § 4.
15
Id. at § 1(1).
9
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an author, writer, artist and researcher and the way to profit from the work of ownership rights to organize
issues pertaining to the copyright.”16
As Copyright gives an economic value to copyrighted products as a trading subject, it plays an
essential part in the development and industrialization of the world, including creative industries.17 As the
creative industry includes broadcasting, film, music, electronic publishing, video/computer games,
advertising, and web design,18 which represent a combination of culture and commerce with the ability to
provide a distinctive image of a country, and show cultural diversity.19 It also limits the creativity
opportunities and consumers’ access to copyright-protected materials in LDCs, including Afghanistan
which will be discussed in this paper.

B. Who is the Author?
The word “author” is used twenty one times in 17 U.S. Code § 101 to define copyrightable works
in U.S. law.20 While the provision does not define who is the author? rather it focuses on determining which
work of the author is protectable.21 In contrast, the Copyright law in Afghanistan defines the author as the
person who creates the work, as it states “[a]uthor, writer, artist and researcher in this law are names as
those who create.”22
Moreover, joint authorship has been discussed similarly in the laws of both countries. Except that
in the United States, the courts have the authority to define what could be a joint work. The court in Lindsay
v. TITANIC defined joined authorship as “the author and joint authors of the work, owns the Copyright over

16

WIPO IP Portal, Afghanistan: Law Supporting the Rights of Authors, Composers, Artists and Researchers
(Copyright Law), art. I, available at https://wipolex.wipo.int/en/legislation/details/10197.
17
WIPO IP Portal, United States of America [Guide on Surveying the Economic Contribution of the Copyright
Industries] (last visited Apr. 3, 2021), available at
https://www.wipo.int/edocs/pubdocs/en/copyright/893/wipo_pub_893.pdf.
18
Bethany Klein et al, Understanding Copyright: Intellectual Property in the Digital Age (2015).
19
John Newbigin, What is the creative economy? (2015), available at
https://creativeconomy.britishcouncil.org/guide/what-creative-economy/.
20
17 U.S.C. § 101 (2011).
21
Id.
22
Afg. Copyright Law, supra note 16, at art. 2.
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that work.”23 Later the court in Erickson v. Trinity Theatre, Inc. introduced the two elements of joint
authorship: (1) to create joint work, each author must intend respective contributions to be contribution to
unitary whole, (2) collaborators are not joint authors unless they intended to be joint authors when work
was created and each author’s contributions to works are independently copyrightable.24 Although the court
in different cases narrowed down this definition by saying that a consultant to a movie is not a co-author
and would not get a copyright for the work,25 or unedited, raw footage is subject to protection.26
Afghanistan’s Copyright law illustrates that if more than one person participates in the creation of a work,
each of them will be entitled to the economic rights of the work, as the owners.27 The law does provide any
limitation on how each author’s participation shall be. Although, it has different provisions on joint musical
works,28 or co-authorship in an audiovisual work.29
Furthermore, the court in Rouse v. Walter & Assocs., L.L.C. discussed the concept of work for hire
and stated that the employer would own the copyright when: (1) all works by an employee is work for hire,
(2) the works prepared by non-employees can be works made for hire if there is an employment agreement
between the parties, and if the work falls within the scope of the employee’s work.30 While, in Afghanistan,
the employer owns any work created by the employee, unless there is a different agreement between them.31

C. Copyright Subject-matter
Section 102 (a) of the Copyright Act in the U.S. defines the extent of copyright protection and
subject matters that are copyrightable.32 It states:
“copyright protection subsists, in accordance with this title, in original works of authorship
fixed in any tangible medium of expression, now known or later developed, from which they can
be perceived, reproduced, or otherwise communicated, either directly or with the aid of a machine
23

Lindsay v. Wrecked & Abandoned Vessel R.M.S. TITANIC, No. 97 CIV. 9248 (HB), 1999 WL 816163 (S.D.N.Y.
Oct. 13, 1999).
24
Erickson v. Trinity Theatre, Inc., 13 F.3d 1061 (7th Cir. 1994).
25
Aalmuhammed v. Lee, 202 F.3d 1227 (9th Cir. 2000).
26
16 Casa Duse, LLC v. Merkin, 791 F.3d 247 (2d Cir. 2015).
27
Afg. Copyright Law, supra note 16, art. 23.
28
Id. at art. 25.
29
Id. at art. 26.
30
Rouse v. Walter & Assocs., L.L.C., 513 F. Supp. 2d 1041 (S.D. Iowa 2007).
31
Afg. Copyright Law, supra note 16, at art. 11(3).
32
17 U.S.C. § 102(a).
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or device. Such works include: (1) literary works, (2) musical works including accompanying
words, (3) dramatic works accompanying any music, (5) pantomimes and choreographic works,
(6) pictorial, graphic, and sculptural works, (7) motion picture and other audiovisual works, (8)
sound recordings, and (9) architectural works.”33
Although this section says that any original work of an author fixed in a tangible form could meet
the criteria for copyrightability, the law does not define the terms ‘original’ or ‘fixed’,34 it is for the courts
to define what is original. The court in Sarony v. Burrow-Giles Lithographic Co. determined that
photographs could be protected as original works because of creative elements in the picture such as
lighting, organizing, shadows, and the nighttime setting,

35

while a plain picture which does not have any

creative element, or it is not edited, or the photographer did not set up the background, will not be
protected.36 Later, the court in Bleistein v. Donaldson Lithographing Co. lowered the originality criteria
stating that a picture is copyrightable regardless of meeting the Sarony test.37
Furthermore, the Feist Publications, Inc. v. Rural Tel. Serv. Co. gave general requirement of
originality. 38 The court ruled that an independent creation with some minimum degree of creativity would
be copyrightable, that the author shall independently create the work, and it must possess some minimal
degree of creativity. 39 The court applied the “sweat of brow” doctrine in its determination that the minimum
degree of originality requires the author to show some effort toward creating the work.40 Later in Mannion
v. Coors Brewing Co., the court gave a three-step test to show the originality of photographs: (1) Rendition
(2) Timing, and (3) Creation of the subject (creation of something that did not exist in nature, until the
person made the scene for the photograph. 41

33

Id.
Id.
35
Sarony v. Burrow-Giles Lithographic Co., 17 F. 591 (C.C.S.D.N.Y. 1883), aff'd, 111 U.S. 53 (1884).
36
Id.
37
Bleistein v. Donaldson Lithographing Co., 188 U.S. 239 (1903).
38
Feist Publications, Inc. v. Rural Tel. Serv. Co., 499 U.S. 340 (1991).
39
Id.
40
Id.
41
Mannion v. Coors Brewing Co., 377 F. Supp. 2d 444 (S.D.N.Y. 2005).
34
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The idea-expression doctrine is also an important discussion of copyrightability in the United States
because the ideas are not protected but the expressions are, and it often raises in Copyright litigations related
to the Copyright infringement cases.42
For writings, the court in Hoehling v. Universal City Studios, Inc. determined that historical and
factual writings are not protectable because the author did not create them, the information already existed.43
The court also discussed the “scene a faire” doctrine which refers to a principle in Copyright law in which
certain elements of a creative work are not protected because they existed customary to the genre, or they
are clichés.44 The Derivative works are protected under 17 U.S.C. § 103 if the author adds some creativity
to a work that is already in the public domain.45 The protection would only be extended to the additions by
the author, while the copied part would remain in the public domain.46 However, the author cannot create
a derivative from a copyright-protected work, unless the author has the authorization to do so.47 Besides, a
compilation in the United States is protected if it is a: (1) collection and assembly of preexisting works, (2)
selection, coordination, and arranging, and (3) creation of an original work of authorship.48 Hence, the
databases are protected49 because they are a compilation of letters, arranged in a certain way,50 as long as
the author’s work of compiling results in making something new and original.51
The Afghanistan Law states:
“the original works of authors shall be protected that are fixed (without considering the
value, quality, purpose or the mode of its expression) in one of the tangible mediums of expression
that is known now or means that will be developed later, which are perceived, reproduced or
communicated in a different way either directly or with the aid of a device.”52

42

Baker v. Selden, 101 U.S. 99, 25 L. Ed. 841 (1879).
Hoehling v. Universal City Studios, Inc., 618 F.2d 972 (2d Cir. 1980).
44
Id.
45
L. Batlin & Son, Inc. v. Snyder, 536 F.2d 486 (2d Cir. 1976).
46
Id.
47
Schrock v. Learning Curve Int’l, Inc., 2005 WL 2870728 (N.D. Ill.).
48
Id.
49
Experian Info. Sols., Inc. v. Nationwide Mktg. Servs. Inc., 893 F.3d 1176 (9th Cir. 2018).
50
Roth Greeting Cards v. United Card Co., 429 F.2d 1106 (9th Cir. 1970).
51
Satava v. Lowry, 323 F.3d 805 (9th Cir. 2003).
52
Afg. Copyright Law, supra note 16, at art. 5.
43
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This definition is very close to how American laws define copyrightable subject matters.53 The
Afghanistan law also requires the work to be either original or fixed in an intangible medium of expression.
Besides, the legislator tried to anticipate that what works could be original or fixed in Art. 6, which lists all
the works that could be protected and it includes:
“(1) Book, pamphlet, brochure, essay, play and other academic technical and artistic
writings; (2) Poem, melody, song and compose that has been written, recorded or published using
any mean; (3) Audiovisual work for the purpose of performance on a movie’s scene or broadcast
from radio or television that has been written, recorded or published using any mean;(4) Musical
work which has been written recorded or published by any mean; (5) Painting, picture, design,
drawing, innovate geographical cartography, linear writings, decorative lines and other decorative
and imaginary works which have been created using any simple or combinatory mean or mode; (6)
Statuary (sculpture); (7) Photography work that has been created using an innovative mode; (8)
Innovative work of handicraft or industrial art (carpet designs, rugs, felt carpet and its attachments
etc.); (9) Innovative work which has been created based on the public culture (folklore) or national
cultural heritage and art; (10) Technical work with an innovative aspect; (11) Computer programs;
and (12) Derivative works.”54
Although having everything mapped out in the law makes it easier for the Judges to apply the law,
and evaluate what work is protected, or whether the infringement happened. It also has the disadvantage of
limiting the Judges to the words of the law, especially when the case is about a situation that is not
anticipated by the legislature.

D. Copyright Terms (How long the Protection lasts?)
When it comes to the terms of copyright protection, the United States has very complicated
procedures to calculate the protection periods, compared to Afghanistan. According to the United States
Copyright Act of 1909, the Copyright protection starts upon publication with formalities, and it will last for
twenty eight years with the possibility to renew for another twenty eight years, for a total of fifty six years.55
While the Copyright Act of 1978, suggests three types of protection terms.56

53

17 U.S. Code § 102 (a).
Afg. Copyright Law, supra note 16, at art. 5.
55
Jane Ginsburg et al., Concepts and Insights, Copyright Law (2012), available at
https://subscription.westacademic.com/Book/Detail/20607.
56
Id.
54
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First, according to 17 U.S.C. § 302, which discusses the contemporary or modern works, covers all
the works which are created on or after 1/1/1978.57 The protection term on the works is the author’s lifetime,
and seventy years after the author’s death.58 In works of joint authorship, the protection will last for the
author’s lifetime and seventy years after that.59 For works for hire, the period would be ninety five years
from the first date of publication or 120 years from the date of creation.60 Then, based on 17 U.S.C. § 303,
which discusses unpublished manuscripts, the protection term will be the lifetime of the author and seventy
years, which will last until 12/31/2002,61 if the work was published before that, then the copyright will last
until 12/31/2047.62 Lastly, based on 17 U.S.C. § 304, if a copyright-protected work is in its first term on
1/1/1978 the protection will be for twenty eight years with renewing possibility for another twenty eight
and then sixty seven years; which will be a total of ninety six years of protection.63 Moreover, if the work
was in its second term on 1/1/1978, and it was validly renewed during its first term, the protection of the
second term would last for forty seven years; which gives seventy five years protection in total. However,
if the Copyright was still enforced by 1998 (Sonny Bono Act), then the second term will last sixty-seven,
giving ninety-five years of protection in total.64
While United States law gives the rule and formula to calculate the protection term, the laws in
Afghanistan give specific timelines to each of the copyrighted materials mentioned in Article 6 of the
Copyright laws.65 It suggests as following:
“(1) Author’s work- Life of the author and 50 years after the author’s death for works published or
broadcast.66 (2) Joint work- Life of the last author and 50 years after the last author’s death for
joint-works, if the is works published or broadcast during their life cycle.67 (3) Anonymous work50 years after the first years of publication for works published or broadcast with metaphorical
(pseudonym). If the author is identified, the provisions of clause 1 of this article shall apply. 68 (4)
57

Id. at 74-75.
Id.
59
Id. at 83.
60
Id. at 102.
61
Id. at 84.
62
Id.
63
17 U.S.C. § 304 (2019).
64
Ginsburg, supra note 55, at 77-83.
65
Afg. Copyright Law, supra note 16, art. 16.
66
Id. at art. 16 (1).
67
Id. at art. 16 (2).
68
Id. at art. 16 (3).
58
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Works which was not published during the lifetime of the author- 50 years from the first year of
publication.69 (5) Audiovisual works- 50 years effective from the first year of the publication or
broadcast.70 And (6) Photography and painting work- 50 years effective from the first year of
publication and broadcast.”71
Although Art. 17 focuses on the point that the protection starts from the date of publication.72 Article 19
gives the broadcasting organizations the right to reproduce their publications and have the Copyright for
another twenty years from the date of re-publication.73 Furthermore, performers have Copyright over their
performance, from the day of performance, for fifty years.74

E. The Author’s Exclusive Rights
The 17 U.S.C. § 106 of the United States lists the exclusive rights of Copyright owners in the United
States.75 The Copyright owner has the right to (1) reproduce the Copyrighted work; (2) to prepare derivative
works based upon the Copyrighted work; (3) to distribute copies or phonorecords of the Copyrighted work
to the public by sale or other transfer of ownership, or by rental, lease, or lending; (4) to perform
Copyrighted work; (5) to display Copyrighted works; and (6) to perform the sound recording publicly in
case of sound recordings.76 However, § 106 (A) recognizes the rights of certain authors to attribution and
integrity.77
While Art. 9 of the Copyright Law in Afghanistan states “the author has the exclusive copyright to
publish, broadcast, present and perform the work and has the right to enjoy economically and morally his
name and his work.”78 It also protects the author’s moral rights which are non-transferable, and only given
to the author, or the employer in case of work for hire.79 The moral rights include the author’s choice if they
want to mention their name or metaphorical name; it bans on any kind of use from the author’s work that

69

Id. at art. 16 (4).
Id. at art. 16 (5).
71
Id. at art. 16 (6).
72
Id. at art. 17.
73
Id. at art. 19.
74
Id. at art. 22.
75
17 U.S.C. § 106 (2019).
76
Id.
77
17 U.S.C. § 106(a).
78
Afg. Copyright Law, supra note 16, at art. 9.
79
Id. at art. 11.
70
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negates the reputation and credibility of the author; and it bans any objection on any kind of alternation,
change of form or possession of the work.80

F. The Impact of Copyright in Least Developed Countries
Copyright protection is important to encourage creativity and motivate the creation of more content,
and it eventually contributes to the development and promotion of a country’s economy.81 However,
copyright protection has its risks and challenges for the LDCs. For instance, copyright imposes economic
and social costs on society. 82 Economic as it provides protection for new works while most of the people
cannot afford it hence it limits new creations, and social as it limits access to information in LDCs.83
Furthermore, as Christian Handke states that “[i]n the short run, a rational Copyright policy trades off rights
holder interests against user interests.”84 .
The WIPO report shows that despite having no doubt that strong Copyright protection would imply
a greater level of creativity, the survey shows that consumers are not willing to pay for that product.85
Besides discussing the reports of surveys in which the consumers show different levels of willingness or
unwillingness toward paying for copyrighted materials, considering their needs in a different jurisdiction,86
the author also discusses the main challenges that copyright protection raises in LDCs, such as (a) Access
to technology, (b) poverty, and (c) demands.

80

Id.
Shahid Alikhan, The Role of Copyright in the Cultural and Economic Development of Developing Countries, J.
Intell. Prop. Rights, at 489, 490 (Nov. 2002), available at
http://nopr.niscair.res.in/bitstream/123456789/4938/1/JIPR%207(6)%20489-505.pdf.
82
Jodie Driffin, Public Knowledge, The Economic Impact of Copyright, available at
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1. Access to Technology
Technology plays a significant part in a country’s development and promotion of IP. Technologies
that are transferred to other countries on an international level play an important role in the development of
the country. The LDCs could copy the technology models and develop them at low costs because they can
have access to supplies at lower costs.87 However, they are not allowed to copy the models or materials that
DCs have; or that they cannot develop or create similar products due to fear of infringing the protected
materials, which ties their hand to do anything.88
The WIPO paper also relies on the point that the innovation process is cumulative and it needs a
starting point.89 It implies that the LDCs need exceptional treatment, that they shall be granted authorization
to access/use some protected technologies, as a guide or raw material to build their own technologies. Then,
these countries can start developing their own products, otherwise, they are trapped in this cycle of poverty
and cannot have a starting point to benefit IP or its economy.
2. Poverty Challenges to Afford Access to Protected Materials
Another problem that LDCs face is poverty. These countries have lower incomes and weaker
economies.90 So, they require different Copyright standards.91 Applying the same international standards to
DCs and LDCs does not help the LDCs, and it also deprives them of having access to certain information,
products, or technologies. For instance, access to information, books, media programs, and streaming
websites are easily affordable in the United States, but it is not affordable by most people in Afghanistan
considering the currency differences and people’s net income.92 However, numerous people do not even
have stable monthly income due to limited employment opportunities.
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3. Demands (Necessity) to use Protected Materials
As the DCs have the resources to initiate and afford Copyrighted materials and the facilities for
sharing information among each other.93 For instance, the peer-to-peer technologies at schools help the
students easily access the materials they need, and later develop new contents, and the cycle goes on.
Specifically, when the schools buy the Copyrighted materials and make them available to their students.
Although the demand stays the same and considering the international standards the LDCs shall serve the
student’s similarly as the DCs. While in Afghanistan, the students, schools, and universities do not have
access to peer-to-peer sharing technologies that provide information, materials, and resources because they
cannot afford such access. Hence, while the demand stays the same, lack of sources and access to
Copyrighted materials can harm LDCs more than it can benefit them.

G. Copyright Limitations
The WIPO defines Copyright exceptions as a balancing method between the interests of copyright
holders and users of protected works.94 It also identifies certain exceptions for economic rights, in which,
one can use a protected work without being authorized by right-holder, nor paying compensation.95
Although, the copyright’s legal framework provides numerous rights for authors, composers, and artists to
control exploitation or reproduction of their works,96 but, nowadays creators need more exceptions rather
than exclusive rights.97
The legal forum, addressing the usage of Copyright exceptions is at the national and international
level. At the international level, the Berne Convention,98 TRIPS Agreement99 and Marrakesh Treaty100
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facilitate the application of copyright exceptions by allowing beneficiaries and authorizing entities to make
accessible copies of protected contents and exchange them across the border, which constitutes legal bases
for copyright exceptions.101 Quotation, criticism, and review of protected works are permitted by the Berne
Convention102 and the TRIPS agreement.103 Besides, parody is defined as “ridicule, distortion, mockery”104
is also an exception to copyright infringement.
The United States applies the ‘fair use’ test, to evaluate whether the copy is fair. The Congress
made fair use doctrine, a statutory limitation on Copyright protection by adding § 107 into the Copyright
Law of 1978. It also considered the application of four factors while evaluating a fair use defense. Such as
(1) the purpose and character of the use, if it is a commercial use for nonprofit educational purposes; (2)
the nature of the copyrighted work, if it is published or not; (3) the copied amount and whether the copied
portion is a substantial part of the protected work; and (4) the effect of the use upon the potential market
value of the copyrighted work. In Sony Corp. of America v. Universal City Studios, Inc.,105 the Court found
that home videotaping of free broadcast television programs, for more convenient time-shifting purposes,
constituted fair use. Although, the Supreme Court in Harper & Row Publishers, Inc. held that “fair use is
a mixed question of law and fact,”106 implying that the Court must be free to evaluate the doctrine and apply
it on a case-by-case basis. However, § 107 is intended to restate the present judicial doctrine of fair use, not
to change, narrow, or enlarge the fair use doctrine in any way.107
Considering the challenges that the LDCs are dealing with, the application of the fair use doctrine
and its factors, will not allow the creator in LDCs to copy a substantial part of the work or make it for
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commercial purposes. Hence, this could not be considered as a chance to let LDCs start having their own
technologies or gaining profit from it.

H. Conclusion
As much Copyright protection would encourage the content creators and authors to produce more
creative works, which will lead the country toward the development of creative technology and creative
economy. That much it will have disadvantages to the creators in LDCs as their access to technology is
limited and the high price of protected material is not affordable for them.

III.

PATENT AND ACCESS TO PHARMACEUTICAL PRODUCTS
In this section, the paper will discuss that how patenting pharmaceutical breaches the human right

of access to medicine. This first compares the patent laws of the United States and Afghanistan; then, will
generally focus on DCs and LDCs to show the impact of patenting pharmaceuticals.

A. Overview
The United States Constitution sets the base for adopting patent laws, as the Constitution states
“promote the progress of science and useful arts, by securing for limited times, to authors and inventors,
the exclusive right to their respective writings and discoveries.”108 The promotion of useful art in this section
refers to patenting the inventions. A patent is granted to the “inventors” and “discoveries” and it shall only
be issued when the invention or process is novel which did not exist before. Similarly, in Afghanistan, the
patent law was issued considering the Art. 47 of the Constitution to support the economic and intellectual
rights of inventors and discoverers,109 in order to support the inventors and encourage inventions and
discoveries.110 Art. 4 states that the invention and discoveries would be supported by law if they are

108
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registered according to the provisions of this law.111 This could imply that those inventions which are not
registered yet, would not be supported.112

B. Patentability
Based on Section 102 of the patent statute, the United States has “the first to invent” rule,113 while
Afghanistan has “the first to file” rule.114 First to invent means the first person who invented the invention
would be eligible to get the patent on his invention; while first to file means the first person who files to
register the patent shall have the patent. The “first to file” rule is mostly used by countries other than the
U.S. because the registration formality determines who started the process first, but it is challenging to
apply when someone commits fraud and tries to register someone else’s invention. In that case, the first
inventor has the burden to prove that the invention was his. The “first to invent” rule also has its own
challenges, as the first inventor has to prove that he is the first inventor.
Section 102 of the patent statute also gives some circumstances in which the invention losses its
novelty. The first four situations discuss the events that take place after the invention is completed, before
the inventor files to register his patent. Most of such situations cause the invention to lose its novelty- which
is called “anticipation.”115 While the U.S. Patent Statute explains what constitutes a breach of novelty
requirement, such as prior patent, publication, use or knowledge by another,116 single sources with an
enabling disclosure,117 prior domestic use or knowledge while foreign use or knowledge would not breach
the novelty, the prior use was public,118 prior invention by another person,119 and unclaimed disclosures in
U.S. Patents and Applications.120
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According to Art. 7 of Afghanistan’s Patent Law, which discusses ineligibility to get a patent on a
financial chart, complementary inventions, and discoveries that are against the public order, morality, public
health and environment, or pharmaceutical formulas. Although pharmaceutical patents generate a high
income in DCs, Afghanistan’s patent law does not grant protection for pharmaceuticals to ensure access to
medicine.

C. Patent Terms (Duration of the Protection)
The duration of patent protection in the U.S. is for twenty years, this term could be extended 1 day
for each day after the end of three years, which adds another seventeen years to the patent protection.121
Once a patent is expired, the contract containing payment of royalty fee would be held invalid.122 The Patent
law of Afghanistan also grants the protection for twenty years, that the inventor or discoverer can have
monopoly and exploitation right over the invention.123

D. Patenting Pharmaceuticals under TRIPS Agreement
The Trade Related Aspects of Intellectual Property Rights (TRIPS) came into existence after the
Uruguay negotiations, by the WTO member states, as the international community lacked a uniform system
to protect IP rights.124 The adoption of the TRIPS agreement was to reduce distortion and impediment in
international trade, secure legitimate trade in goods and services, and define a minimum standard for IP
protection,125 which includes protecting pharmaceutical products.126 To reach these objectives, all WTO
members are obliged to undertake some provision for IP protection in their national legislation and ensure
compliance with the TRIPS agreement.127 The DCs supported this system, while the LDCs objected, stating
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that it would limit access to medicine. However, the TRIPS agreement provides some flexibilities to support
the LDCs too.
1. Obligation of the Signatory Members States
When it comes to the implementation of the TRIPS agreement, different countries have different
standards depending on their economic status and legal forum. Article 1 of the TRIPS agreement requires
the member states to implement this agreement in their national laws, and Article 2 adds more emphasis on
the implementation of Art. 1 of the TRIPS agreement and Art. 19 of the Paris Convention 1967.128
Therefore, there is an obligation for member states to enforce the minimum standards of the TRIPS
agreement. The TRIPS agreement is binding on all WTO member states and they must comply with the
TRIPS agreement provisions and establish patent protection standards in their jurisdiction.129
Although the TRIPS agreement obliged member states to comply with it after January 1, 1995, it
also provided a transaction period of four years to developing countries130 and ten years for LDC,131 to bring
their national legislation in compliance with the TRIPS agreement. To further ease the burden of LDCs, the
WTO designed a Cooperation Agreement to provide technical and financial assistance for LDC.132
However, such cooperation is not sufficient as there are no significant changes in the list LDC since 2002133
compared to 2018.134 Although this only facilitates the LDCs to bring their legislation in compliance with
the TRIPS agreement, it does not guarantee access to medicines.
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2. Patenting Medicine
Article 27(1) of the TRIPS agreement sets minimum standards for patenting an invention, stating
that “patents shall be available for any invention, whether products or processes, in all fields of
technology.”135 It adds that patents shall be novel, involve an inventive step, and be capable of industrial
applications, regardless of the place of invention, the field of technology, and whether products are imported
or locally produced.136 This Article applies to all member states of the TRIPS agreement and obligates them
to adopt their own IP protection laws for medicines, while it does not provide any recommendation on how
much protection is necessary, which enables the member states to define patentability standards in their
national legislation or to refuse to grant patents for some subject matters.137 Approximately fifty WTO
members objected to patenting medicines during the TRIPS agreement negotiations as they did not agree
to provide patents for medicines,138 as they argued that access to medicines shall be a human right.
Granting patents for pharmaceutical products, allows the pharmaceutical companies to increases
the price of medicine, as the generic companies are unable to produce drugs, it limited the availability of
the drug and elevated the market demand for patented drugs which led pharmaceutical companies to set a
high price over patented drugs.139 For instance, Gilead, a pharmaceutical company, decided to sell a drug
called Sovaldi for treating Hepatitis C, for 84,000 USD per course of treatment.140 This was not affordable
for most people, especially in LCDs. It is also in contrast with the right to health and well-being under the
Universal Declaration of Human Rights,141 while accessibility and availability of drugs are the main
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objectives of public health policy in all countries.142 It will also give pharmaceutical companies the power
to control the export and import of patented drugs.143
Granting pharmaceutical patents also allows the Pharma companies to control the availability of
medicines in the market, as the patent holders will claim monopoly right upon patented drugs, and it bans
generic companies from producing the generic form of patented drugs.144 It pushes the generic companies
out of the market, and the TRIPS agreements became the greatest achievement for the big Pharma
companies for granting them monopoly rights over the market and price of the drugs. 145
Although granting a pharmaceutical patent was to encourage the pharmaceutical companies to open
up to the public about their drugs; give information to the public, and encourages innovation for the future
long-term investigation.146 The reports show that there has been a significant decrease in the development
of innovative drugs and limitations in accessing the data, which causes a lack of transparency and raises
concerns about the safety and efficacy of medicines.147 This shows that patenting drugs would not lead the
WTO to reach its objectives.
In addition, pharmaceutical companies conduct R&D on the diseases which affect wealthier people
in DC, because they have a profitable market there.148 They do not invest in diseases affecting poor people
in LDCs as poor people cannot afford the drugs.149 Therefore, R&D would not make any difference in
developing and LDCs as long as the patients are not able to receive drugs.150 A majority of infected people
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by HIV/AIDS, Malaria, TB, and Hepatitis C are living in developing and LDC countries with no ability to
afford medicines. 151 For instance, a study shows that 40 million people were infected by HIV in developing
countries, out of them, 24. 5 million lived in Sub-Saharan Africa and 8,000 people have died for not having
access to medicine.152 The global HIV/ AIDS statistic shows that 36.9 million people were infected by HIV
in 2017.153 Similarly, another source shows that more than 10 million people die due to HIV/ AIDS,
respiratory infection, malaria, and tuberculosis in Africa, Asia, and South America per year.154
i.

Misuse of Big Pharma

Pharmaceutical companies that enjoyed monopoly rights over their patented drugs for twenty
years,155 tend to keep their monopoly and extend their patents by applying different approaches, to either
push the generics companies out of the market,156 or to stop the issuance of a compulsory license.157
The pharmaceutical companies apply different methods to keep the generic companies out of the
market. Such as, ever-greening practices that allow them to extend the protection beyond the term of a basic
patent.158 For example, in the case of Abbott v. Teva Inc., Abbott changed the formulation of its drug called
‘TriCor’ and obtained a new patent on its new formula for another twenty years.159 Moreover, the pay for
delay agreement is another method via which the pharmaceutical companies pay the generic companies to
stay out of the market. In 2013, the European Commission fined some pharmaceutical companies for
entering into such agreements to delaying the market.160 For instance, Lundbeck Company was the producer
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of the ‘citalopram’ and entered into six different agreements with four generic companies to keep them out
of the market.161 The European Commission fined it 93.8 million euros, fined Novartis for 16 million euros,
and generics company for 98 million euros.162
Preventing the issuance of compulsory licenses is another method that pharmaceutical companies
apply to prevent generic products from entering the market. In the case of Big Pharma v. Nelson Mandela,
Nelson Mandela’s government amended the Act, allowing affordable drugs to be available in the market.163
Forty pharmaceutical companies sued South Africa’s government for violating the TRIPS agreement and
the United States put political pressure on South Africa by setting sanctions and banning trades. 164 In the
case of Kaletra, Thailand decided to issue a compulsory license on Kaletra to cure HIV/AIDS-infected
people in Thailand.165 The United States and pharmaceutical companies used their political power to
pressure Thailand to stop issuing compulsory licenses.166 Similarly, India faced pressures when it issued a
compulsory license for Bayer’s cancer (Nexavar), as Andrew Jenner, executive director of the International
Federation of Pharmaceutical Manufacturers said the “[i]ncreased use of compulsory licensing will reduce
the incentive to invest in the R&D of new medicines in India.”167 Furthermore, the Office of the United
States Trade Representative (OUSTR) report also placed Algeria, China, Indonesia, and Thailand on the
list for “failing to protect intellectual property rights” for trying to issue compulsory licenses.168
However, the competition law and patent misuse doctrine exist which “prevent a patentee from
using its patent to obtain market benefit beyond the statutory patent right,169 but such misuses still happen.
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3. Flexibilities under TRIPS Agreement
The Art. 31 of the TRIPS agreement, allows the usage of patented products without authorization,
170

and, Doha Declaration in 2001 added to the importance of health protection rather than IP protection,171

to support the special needs of the LDC.172
i.

Compulsory Licensing

Article 31 of the TRIPS agreement allows compulsory licenses to promote access to medicine and
health.173 Article 31(a) allows other uses of products without authorization of the right holder,174 which
means compulsory licenses. In 2012, India issued a compulsory license for Bayer’s cancer drug sorafenib
(Nexavar) as the Indian courts decided that the costs of USD 4,500 a month for sorafenib were unaffordable
and the generic version of the drug was available for USD 175 a month.175 Indonesia also issued compulsory
licenses on seven hepatitis B and HIV treatments. In Thailand, compulsory licenses have mainly been issued
for HIV drugs.176 In 2001, South Africa, under the Nelson Mandela government, started importing and
producing generic form medicines.177 However, Art. 31 of the TRIPS agreement only allows the issuance
of generic drugs, locally, to supply the needs of the local market.178 While most of LDCs do not have the
capacity and facilities to manufacture generic drugs locally.179 This was discussed in Doha Declaration.

ii.

Doha Declaration

170

TRIPS Agreement, supra note 95, at art. 31.
Essential Medicines and Health Products Information Portal (2020), World Health Organization, available at
https://digicollections.net/medicinedocs/#p/home.
172
TRIPS Agreement, Preamble available at https://www.wto.org/english/docs_e/legal_e/trips_e.htm#preamble.
173
TRIPS Agreement, supra note 95, at art. 31.
174
Id. art. 31.
175
Patent wars: affordable medicines versus intellectual property right (2014) 348, BMJ, 15 available at
https://www.bmj.com/bmj/section-pdf/752708?path=/bmj/348/7947/Feature.full.pdf.
176
Alcorn, supra note 156.
177
Ellen F. M. Thoen, TRIPS, Pharmaceutical Patents and Access to Essential Medicine: Seattle, Doha and Beyond
(2003), available at https://www.who.int/intellectualproperty/topics/ip/tHoen.pdf. See also in Mandisa Mbali,
Pharma v. Mandela: South African Moral Capital in a Global Movement, 1998- 2001(2013), available at
https://link.springer.com/chapter/10.1057%2F9781137312167_6#citeas.
178
TRIPS Agreement, supra note 95, at art. 31(f).
179
Paas, supra note 145.
171

25
Published by University of Cincinnati College of Law Scholarship and Publications, 2021

25

The University of Cincinnati Intellectual Property and Computer Law Journal, Vol. 5, Iss. 1 [2021], Art. 6

Doha Ministerial Conference in 2001 recognized the importance of health over new medicines, as
well as the concerns about its effects on medicine prices.180 The Doha Declaration waived the requirement
of Art. 31(f) of the TRIPS agreement by allowing the DCs to obtain compulsory licenses and produce
generic forms of drugs to export them to developing or LDCs.181 Section 7 of the Doha Declaration allowed
the DCs to obtain compulsory licenses and produce generic forms of the drugs to export them to developing
or LDCs which do not have the ability to manufacture pharmaceutical drugs.182

E. Conclusion
Patenting medicines under the TRIPS agreement is a sign of development with the possibility of
encouraging innovation in the future. However, the disadvantage of patenting pharmaceuticals is larger.
However, the WTO and the TRIPS agreement council tried to provide more flexibilities to developing and
LDCs and efforts to prevent misuse of IP rights by pharmaceutical companies or DCs, but big Pharmas has
grown stronger and capable of taking different approaches to monopolize the market. The fact that big
pharmaceutical companies have the power to hold the market, legally or illegally, makes it harder for
countries themselves.

IV.

TRADEMARKS AND CHALLENGES OF POOR COUNTRIES
Trademark is a jurisdictional concept that one countries advancement does not negatively impact

the other ones, but this section will focus on how access to the international trading market can negatively
impact the LDCs.

A. Overview
The WIPO defines a trademark as a sign that designates the goods and services of one enterprise
from those of other enterprises.183 A trademark distinguishes one product from another one, rather than
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protecting an invention or a work of authorship, and to avoid confusion about the origin of the goods.184
Although, in modern times, the function of Trademark extended to indicate the origin of the good, guarantee
the quality, serve as a marketing and advertisement device, or respond to the consumer liabilities.185 The
WIPO member states have accepted this definition, and each member state has its own Trademark Office
to register trademarks within its country.186 In addition to the national system that each country has, the
WIPO has an international system for registering cross-border trademarks called the “Madrid System”
which protects trademarks at the international level.187

B. Trademark Subject Matters
The WIPO illustrates that “a word, combination of words, letters, and numerals can constitute a
trademark, it could also be drawing, symbols, three dimensional features- like shape and packaging of
goods, non-visible sign like sounds and fragrances, or color shades used as distinguishable features in
limited occasions.”188 The United States became a member of the WIPO’s Madrid System on November
22, 2003, while Afghanistan became a member of the Madrid System on June 26, 2018.189
In the United States, a Trademark could be a word190 or name,191 but to Trademark a name, the
applicant must show that the public will associate that name with their products.192 Moreover, colors193 and
dressing, which is about multiple color schemes, can also be eligible to register as Trademarks.194 A
product’s design can also be registered as a Trademark if the applicant shows some amount of
distinctiveness that people associate that design with the applicant’s products.195 However, generic words196
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like “Asprin”197 and words that are functional like “computer programs” are not illegible to register as
Trademarks, unless they show secondary meaning- that people will associate that generic word with their
products.198 While, arbitrary words (made up, or imaginative words) are strongly registerable as
Trademarks.199 Trade dress are registerable if they are inherently distinctive, if not, they have to show
secondary meaning. Furthermore, a single color and product designs are never inherently distinctive, and
the applicant always has to show secondary meaning. Combinations of colors could be distinctive, in which
case the applicant does not have to show secondary meaning.
The Afghan laws define trademark similarly as the WIPO, and states “[t]rademarks consist of (one
or more) names, words, signatures, letters, figures, drawings, symbols, titles, seals, pictures, inscriptions,
advertisements or packs or any other mark or a combination thereof.”200 It adds that ownership of a
trademark belongs to the person who used it first.201 However, Trademarks in the United States were
developed via common law only through commercial use, they could be enforced only within the
geographic area in which the commercial activity of the owner was conducted and only between products
that were similar enough to be competitive.202 Afghanistan’s Trademark law protects well-known marks,
even if they are foreign marks from other countries, and does not allow registration of similar or deceptive
marks.203
1. Refusal to Register
Although the courts will evaluate whether a mark is registerable, considering the common law approaches,
the statute law in the United States also lists the absolute and presumed bars for refusal to register a
Trademark.204 Sections 2(a)-(d), 2(e)(3), and 2 (e)(5) are absolute bars that the United States Patent and
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Trademark Office (USPTO) will not register that mark. For instance; if the mark is immoral,205 or
deceptive,206 or scandalous,207 however, the Supreme Court in Iancu v. Brunetti decided that USPTO shall
not block a trademark only merely because it believed that the proposed mark is offensive;208 or if the mark
is disparaging or falsely suggests a connection to the designated goods or services,209 they are not
registerable. As well as, if the mark is a geographical indication, it is not registerable.210 A functional mark
that does not show secondary meaning, is not registerable either.211
Furthermore, Article 6 of the Trademark Law in Afghanistan, covers fifteen items that are not
eligible for trademarks in Afghanistan: (1) national flag; (2) adytum or religious symbols; (3) picture of
national figures; (4) words and phrases that could be confused with Governmental departments; (5) marks
of an official organization; (6) anything against the morality of public order; (7) common traditional names;
(8) geographical names; (9) name, surname, and photo of a third party; (10) misleading marks; (11)
imaginary, imitative or forged names; (12) marks related to juristic or legal entities; (13) another person’s
mark; (14) marks for identical goods: and (15) marks which are used for a specific purpose.212

C. Trademark Term (Duration of the Protection)
The trademark registration would grant an exclusive right to the owner of the mark, to use, sell, or
license it to another person.213 Trademarks do not have limited terms for protection, as each registration
would give exclusive rights for ten years, with the extension possibility for other 10 years, when the first
term comes to an end.214 Both the U.S. and Afghan laws similarly suggest that the term of protection is ten
years, renewable when the term comes to an end.215
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D. Challenges of the LDCs
Trademarks are jurisdictional and they indicate the source of a product, rather than protecting an
invention of work of authorship. Therefore, Trademarks do not pose challenges to the LDCs, as the Patent
and Copyright Protections do. However, it does not mean the LDCs do not face any challenge when it
comes to Trademark related matters. Accessing the international market is a significant challenge for LDCs.
Article II of the Marrakesh Agreement, establishing the WTO, set out the scope of objectives that the WTO
has, which includes instituting the framework to conduct trade relations among member states.216 The
Marrakesh Agreement also highlights that the WTO will facilitate international transactions, provide a
forum for trade negotiations, administer dispute settlements between member states, and administer trade
policies and mechanisms.217 The LDCs can hardly meet the WTO standards to become members of the
WTO, that is why the WTO has 164 members, and only nine of them are LDC, including Afghanistan
which is the ninth LDC in the WTO.218
Afghanistan is a member of the WTO since July 29, 2016,219 while Afghanistan applied for the
WTO membership in 2004. It took twelve years for Afghanistan to work on its legal and institutional
reforms to improve the country’s business, enable the environment, and establish competitiveness with the
help of USAID.220 Although lack of having facilities to process Afghan products inside the country, most
of the formers tends to sell their product to the neighboring counties at a very low price.221 Then, the
neighboring countries would have to process Afghan products and export them to the international market
under their own name and Trademark.222 For instance, a news report from 2017 shows that Pakistan
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imported more than 25,000 tons of Jalghoza from Afghanistan, for the price of 8 USD per kilogram, and
then it sells it to China for more than 30 USD per kilogram.223

E. Conclusion
Trademark is a jurisdictional matter. While the United States follows common law on determining
what could be registerable as Trademark, it follows federal statute in deciding which marks are not
registerable or the process of registering a Trademark. The United States also looks at the prior use of the
mark, based on which grants the registration. In Afghanistan, the Afghanistan Trademark registration law
governs what could be registerable as a mark, or not. As well as, it illustrates the process of the register
along with the Afghanistan Canter for Business Registration and Intellectual Property (ACBR-IP).
Although, DC’s Trademark system would not negatively impact the LDCs’ trademark registration or
activities but accessing the international market does. As most of the LDCs do not meet the WTO standard
to join the WTO, they are less involved in international business-related negotiation, or transaction. Hence,
they have to sell their product at a lower price. While the purchasing countries can process those products
and export them under their own name and Trademarks.

V.

CONCLUSION
The IP protection, indeed, recognized the intellectual work of the author, inventors, and creators. It

indeed encourages more people to create novel inventions, work for the advancement of science and
technology, or create entertaining content. It also, indeed, contributes to the development of creative
industries or the economy of a country, which will eventually promote the country’s social, academic, and
political situation too. Although, IP does not impact all countries in the same way.
To have a strong IP system, a country needs to have a good economy, better access to technology
and resources, so that it can comply with the international standards, or to start benefiting from IP. It will
vary considering the countries’ economic situation. The DCs can get the most out of the IP framework, the
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developing countries can have some advantages, but the LDCs are the ones that not only cannot benefit
from IP protection, but they could be disadvantaged in some manners too.
Although this paper briefly highlighted how IP protection can disadvantage LDCs, this is not a
well-detailed paper. Each of the sections pointed out in this paper, is as deep and detailed that one can write
a book on it. This paper that broadly compares the United States IP law with the IP laws in Afghanistan,
highlights the biggest challenge that LDCs can face in each patent protection, copyright protection, or
Trademark related matter.
Copyright protection guarantees the development of creative industries and the creative economy
in most European and American countries. At the same time, it limits the creativity in LDCs as they do not
have access to information and technology, neither they can afford to have them.
Similarly, patenting inventions guarantee more research, investigation, development, advancement
of science and technology. At the same time, it can be disadvantaging most people in LDCs, even breach
their human rights. For instance, patenting pharmaceutical that encourages pharmaceutical companies, it
also gives them the power to control the market, price, availability, and export/import of medicines.
Trademark is a jurisdictional matter that country’s advancement does not negatively impact the
other one, but access to the international market matter. The WTO has high standards that most of the LDCs
cannot join the WTO, hence they do not have the same trading opportunities as the DCs or developing
countries have. Therefore, this matter needs as much attention as the Patent or Copyright.
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